Medici di Oncologia all'estero — Pagina 3

Professional experience:

• From February 2019 to present: Head of Radiation Oncology Department, Quirónsalud Proton Therapy Center, Madrid, Spain.
• 2017-18: Senior specialist in radiation oncology, MAASTRO Clinic - ZON-PTC (Zuid-Oost Nederland Protonen Therapie Centrum), Maastricht, The Netherlands.
• 2014-17: Senior Radiation Oncologist, Department of Radiation Oncology, University Hospital of Geneva, Geneva, Switzerland.
• 2005-14: Senior Physician in Radiation Oncology, Proton Therapy Center, Paul Scherrer Institute, Villigen, Switzerland.
• 2006: Clinical fellowship in proton radiation oncology, Francis H. Burr Proton Therapy Center, Division of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
• 2005: Medical specialist in radiation oncology, Department of Radiation Oncology, University Hospital of Lausanne, Lausanne, Switzerland.
• 2002-2004: Medical specialist in radiation oncology, Department of Radiation Oncology, University Hospital of Geneva, Geneva, Switzerland.
• 1999-2002: Assistant Physician in Radiation Oncology, Department of Radiation Oncology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain.
• 1999: Assistant Physician in Radiation Oncology, Department of Radiation Oncology, University Hospital Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
• 1994-98: Residency in Radiation Oncology, University Hospital Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.

Education:

• 1984-91: Degree in Medicine and Surgery, Faculty of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
• 2018 to present: PhD candidate, Maastricht University, The Netherlands.

Publications:

Dr. Ares is the author of 34 scientific articles published in peer-reviewed medical journals.

Her extensive international experience and commitment to innovative treatments make her a leading expert in proton therapy and radiation oncology.

Professional experience:

• From February 2019 to present: Head of Radiation Oncology Department, Quirónsalud Proton Therapy Center, Madrid, Spain.

• 2017-18 Senior specialist in radiation oncology, MAASTRO Clinic - ZON-PTC (Zuid-Oost Nederland Protonen Therapie Centrum), Maastricht, The Netherlands.
• 2014-17 Senior Radiation Oncologist, Department of Radiation Oncology, University Hospital of Geneva, Geneva, Switzerland.
• 2005-14 Senior Physician in Radiation Oncology, Proton Therapy Center, Paul Scherrer Institute, Villigen, Switzerland.
• 2006 Clinical fellowship in proton radiation oncology, Francis H. Burr Proton Therapy Center, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
• 2005: Medical specialist in radiation oncology, Department of Radiation Oncology, University Hospital of Lausanne, Lausanne, Switzerland.
• 2002-2004 Medical specialist in radiation oncology, Department of Radiation Oncology, University Hospital of Geneva, Geneva, Switzerland.
• 1999-2002 Assistant Physician in Radiation Oncology, Department of Radiation Oncology, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain.
• 1999 Assistant Physician in Radiation Oncology, Department of Radiation Oncology, University Hospital Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
• 1994-98 Residency in Radiation Oncology, University Hospital Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.

Education:

• 1984-91: Degree in Medicine and Surgery, Faculty of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
• 2018 to present: PhD candidate, Maastricht University, The Netherlands.

Publications:

Dr. Ares is the author of 34 scientific articles published in peer-reviewed medical journals.

Her extensive international experience and commitment to innovative treatments make her a leading expert in proton therapy and radiation oncology.

Il medico è specializzato in ginecologia oncologica e radioterapia, concentrandosi sul trattamento e la gestione dei tumori ginecologici. Con un'ampia esperienza nelle tecniche avanzate di radioterapia, il medico ha contribuito a migliorare i risultati dei pazienti attraverso approcci innovativi nella cura del cancro. Il medico è riconosciuto per il suo impegno nell'integrare la ricerca all'avanguardia nella pratica clinica, garantendo che i pazienti ricevano i trattamenti più efficaci e aggiornati disponibili.<\/p>

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Il medico è un praticante altamente esperto presso il Sourasky Medical Center, specializzato in Medicina Interna e Cardiologia. Con oltre 20 anni di esperienza, il medico è certificato in entrambi i campi. Il focus clinico include Cardiologia, Pneumologia e Medicina Critica, fornendo cure complete per una vasta gamma di malattie e condizioni.<\/p>

Specializzato nei trattamenti per il cancro alle ossa, il Dr. Sokucu applica tecniche ortopediche avanzate a casi complessi presso l'Ospedale VM Medical Park Florya.

• Oltre 14 anni di esperienza in ortopedia e traumatologia
• Ha pubblicato più di 20 articoli di ricerca su trattamenti ortopedici e malattie delle ossa
• Certificato dall'European Board of Orthopaedics and Traumatology
• Formazione specialistica in osteosintesi e gestione delle malattie delle ossa

Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.

Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Il Professor Mehmet Karaca è specializzato nelle tecniche laparoscopiche minimamente invasive per i tumori ginecologici presso il Medical Park Antalya Hospital Complex.

• Formazione in chirurgia oncologica ginecologica da parte del Ministero della Salute
• Oltre 20 anni di esperienza in ostetricia e ginecologia
• Competenza in gravidanze ad alto rischio e isterectomie assistite da robot
• Ex primario clinico presso l'Antalya Training and Research Hospital
• Possiede un dottorato in Ostetricia e Ginecologia presso l'Università di Dicle

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Specializzato in oncothermia – una terapia ipertermica all'avanguardia per il cancro – con 5 anni di esperienza mirata presso il Panacee Hospital Rama2.

• Oltre 14 anni di esperienza nelle tecniche avanzate di radioterapia
• Certificato in terapia Oncotherm – un approccio raro di trattamento ipertermico
• Esperto nella pianificazione complessa dei trattamenti (IMRT, VMAT, 2D/3D)
• Formazione in cure palliative presso l'Università di Khon Kaen
• Fornisce cure complete inclusa l'immunoterapia e la chemioterapia

Oltre 3.500 interventi chirurgici robotici eseguiti – Il Dr. Tvaruzek è un esperto certificato di spicco da Intuitive Surgical, il produttore del robot Da Vinci.

• Dirige il Centro di Chirurgia Robotica presso l'Ospedale di St. Zdislava
• Specializzato in prostatectomia con preservazione della funzione erettile
• Esegue interventi chirurgici transorali per tumori nel rinofaringe, laringe, trachea e bocca
• Membro dell'Associazione di Medicina Estetica e Chirurgia Bariatrica

Dr. Rana Niftaliyeva is an oncologist-mammologist at the Biological Medicine Integrative Health Center in Baku. She specializes in breast cancer treatment and precancerous mammary gland diseases. Dr. Niftaliyeva has participated in medical conferences across Azerbaijan, Germany, and Turkey. She focuses on integrative approaches to cancer care.

• Treats large breast cysts using non-surgical aspiration techniques.
• Provides mistletoe therapy and high-dose vitamin C cancer treatments.
• Manages side effects of chemotherapy and radiation through supportive care.
• Performs biopsies and hormonal therapy for various oncological conditions.

Professional Resume

Basic education

• Electronic Engineering , Buenos Aires (1984)
• Physics of Radiotherapy , National Atomic Energy Commission of Argentina (CNEA, 1984)
• Master of Medical Physics , Universities of Toulouse and Paris (1986)
• Doctor of Science in Medical Physics , Universities of Toulouse and Paris (1990, Stereotactic Radiotherapy)

Publications

• Scientific index: 36.93
• Number of publications: 140

Professional activity

• 1980-1984 – Lecturer, University of Buenos Aires
• 1982-1984 – Academy of National Medicine of Argentina
• 1985-2018 – Institut Curie (Paris)
  • Latest positions:
    • Technical Director of the Proton Therapy Center
    • Head of the Department of Medical Physics

Research Internships as a Visiting Professor

• 2003-2004 – Massachusetts General Hospital & Harvard Medical School (Boston, USA)
• 1998 – Indiana University Cyclotron Facility (Bloomington, USA)

Membership in scientific committees

• 2014 – CERN International Strategy Committee for Medical Applications
• 2000 – Conseil Scientifique National de Hadrontherapie (France)
• 2012 – The Belgian Hadrontherapy Center Foundation
• Scientific and expert consultant for companies: IBA, IBA Dosimetry, Varian Particles, Siemens, Tomotherapy
• Scientific advisor at proton therapy centers in various countries:
  • China (Wanjie)
  • South Africa (Cape Town)
  • USA (Indiana, New York)
  • Italy (Trento)
  • South Korea (Seoul)
  • France (Caen)
  • Netherlands (Maastro)
  • Argentina (Buenos Aires)
  • Austria (MedAustron)
• Member of the Scientific Council at the Embassy of Argentina in France

Reviewing articles for scientific journals

• Physics in Medicine and Biology
• Medical Physics
• Physics Medicine
• Radiotherapy and Oncology
• Radiation Protection Dosimetry
• Radioprotection
• Cureus and others

Membership in scientific societies

• PTCOG (Particle Therapy Cooperative Group) – Chairman (2010-2013)
• ESTRO (European Society for Radiotherapy and Oncology)
• SFPM (Société Française de Physique Médicale)
• PMSF (Physiciens Médicaux Sans Frontières)

Teaching activities

• Master's program "Medical Physics" , Faculty of Medicine, University of Paris-Sud
• School of Proton Therapy ESTRO
• PTCOG Educational Master Classes
• Inter-University Diploma in High-Tech Radiotherapy
• Diploma in Radiation Biology and Radiation Protection in Radiotherapy (France)
• AAPM Summer School , Colorado Springs, USA (2015)
• Scientific supervision of postgraduate students, masters students, interns (up to 10 students per year)
• Invited lectures in various countries around the world (about 10 per year)

Grants and funding received (more than €50 million)

1. MIGAC – New Proton Therapy Centre of the Institut Curie
2. Grant Canceropole
   • (a) Targeted proton therapy for pediatric and adult tumors: technical optimization, radiobiology, socioeconomic assessment
   • (b) Dynamic proton therapy
3. Grant Physician – DEDIPRO (development of a new diamond detector and fast radiation therapy planning system for pulsed proton beams)
4. Industrial and regional grants – Areva 1-2-3, Feder, Varian, etc.
5. European Commission Grants
   • INFRAIA-02-2017 – INSPIRE (Infrastructure for International Proton Therapy Research)
6. IDEX Paris-Saclay – NanoTheRad (research on nanoparticles in medicine)

This specialist has made significant contributions to the development of proton therapy, radiation oncology and medical physics, combining scientific research, teaching and work at the world's leading medical and research institutions.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Prof. Dr. Önder SÜRGİT is a General Surgeon in the General Surgery Clinic. Working hours: 09:00–18:00. Core practice areas include laparoscopic surgery, cancer surgery, and bariatric surgery.

Graduated from Hacettepe Faculty of Medicine in 1995. Academic title: Professor. Served as Instructor Surgeon at ITEM (Advanced Medical Technologies Training Center). Held faculty roles at Turgut Özal University and Atılım University, Faculties of Medicine. Also worked at Ankara Medicana Hospital and Optimed Health Group. Foreign language: English.

Dr. Thanaphat Pomyukon is a general surgeon (ศัลยแพทย์ทั่วไป). Thai medical license no. ว.50550. He earned his M.D. from the Faculty of Medicine, Chulalongkorn University. He also holds the Thai Board Diploma in General Surgery from Roi Et Hospital, Ministry of Public Health.

His clinical focus includes hernias and hemorrhoids. He also treats breast lumps and gallstones. He manages digestive system diseases. He performs gastrointestinal endoscopy, including gastroscopy and colonoscopy.

Languages: Thai (primary) and English (professional clinical level).

Zhang Yanjun, MD, is a Chief Physician and Master’s Supervisor with 30 years of experience in tumor imaging and radiation oncology. He treats both pediatric and adult patients. His focus includes primary and secondary tumors, neuro-oncology, and stereotactic radiotherapy.

He is proficient in radiotherapy for cancers of the lung, liver, nasopharynx, head and neck, esophagus, breast, rectum, cervix, and prostate, as well as lymphoma and central nervous system tumors.

He is a member of the Central Nervous System Tumor Radiotherapy Group of the Second Committee of the Radiation Oncology Physicians Branch of the Chinese Medical Doctor Association. He serves on the Executive Committee of the First Chinese Oncology Radiation Therapy Cooperation Group of the World Association of Chinese Oncology Physicians. He is also a member of the National Digestive Oncology Expert Committee of the Radiation Oncology Professional Committee of the Wu Jieping Medical Foundation. He was a visiting scholar twice at leading U.S. cancer radiotherapy centers. He has published 46 papers in core journals and international conferences.

Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.

He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.

Education/Academic Experience

Apr 1995 – Oct 2001                Medical School of Aristotle University of Thessaloniki, Greece

Mar 2007                                   IELTS Certificate (Overall Band Score 7.5)

Feb 2011                                    CCST in Urology, Aristotle University of Thessaloniki, Greece

June 2012                                  Fellow of the European Board of Urology (FEBU)

Sept 2014                                  Fellow in Andrology/Reconstructive Surgery (Mr Giulio Garaffa,         UCLH / Mid-Essex)

Apr 2016                                   Fellow of the Royal College of Surgeons of England (FRCS Eng)

Oct 2018                                   Honorary Senior Lecturer St Andrews University

Sep 2019                                   Urology ChM Tutor in Andrology and Minimally Invasive Surgery (MIMS) University of Edinburgh

Aug 2020                                  European Union Expert Panel Member of in vitro Medical Devices (EU EXPAMED)

Current and Previous appointments

Current appointment

May 2022- Present         Consultant Urologist German Oncology Centre, Limassol, Cyprus

Previous appointments

Nov16- May 2021       Consultant Urological Surgeon Victoria/ Queen Margaret Hospital Fife, Scotland.

Nov 2012 - Oct 2016      Consultant Urologist Broomfield Hospital, Mid-Essex Hospitals Trust 

Jan 2011 - Oct 2012      Urology Clinical Research Fellow, Spelialist Registrar Level), Bristol Royal Infirmary, United Bristol Hospitals Trust

Dec 2009 -Dec 2010      Urology Resident G. Gennimatas Hospital, Aristotle University of Thessaloniki

Duties

• Performing routine and major Penile / Urethral Reconstruction as well as Core Urology procedures twice weekly at Victoria and Queen Margaret Hospitals (Green light prostatectomy, Urolift Service lead, Prostate template biopsies, General urology)

Consultant Urologist providing and supervising the services of andrology and urethral reconstruction surgery. Also covering a general urology one stop outpatient clinics three times per week (Victoria and Queen Margaret Hospitals).

Participation in once weekly local cancer and once monthly specialist male uro-genital reconstruction MDT meetings (Honorary contract at the Western General Hospital, Edinburgh) as well as grand ward rounds.

Undergraduate student trainer and member of examiners panel at St Andrews University, Scotland.

Participation in 1:9 on call Urology Consultant rota.

Research

• Victoria Hospital, Kirkcaldy (NHS Fife) lead investigator. A prospective, multicentre study with subgroup randomisation into MRI-U/S image fusion guided prostate biopsies and routine transrectal U/S guided biopsies.  (MULTIPROS Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A pragmatic multicentre randomised superiority trial of open urethroplasty versus endoscopic urethrotomy. (OPEN Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A Multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones. (TISU
• Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Randomised Controlled Trial of the Use of Drug Therapy in the Management of Symptomatic Ureteric Stones in Hospitalised Patients. (SUSPEND Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Prospective Single Arm Intervention Trial Evaluating Focal Therapy using High Intensity Focused Ultrasound (Sonablate 500) for Localised Prostate Cancer. (HIFU INDEX Study)
•  
• Bristol Royal Infirmary sub-investigator, A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex). (EDVART Study)

Teaching Experience

Fife Simulation BPH Course Fascilitator (Scottish Urology Training Programme, Queen Margaret Hospital, Dumfermline Fife)

Urology Simulation boot camp Faculty member (St James's University Hospital, Leeds)

General Practitioner Urology Training Programme Fascilitator (ScotGem)

Objective Structured Clinical Examination (OSCE) assessor (St Andrews University Medical School)

Teaching (case-based discussions) and trainee supervision in theatres (East Anglia / East of   Scotland Deaneries trainees)

FY1 Doctors Urology teaching Bristol Royal Infirmary (University Bristol Hospitals Trust)

Undergraduate teaching of medical students in General Hospital of the city of Drama, Greece

Anatomy, Physiology and First Aid to Undergraduate nursing students